Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Expert systems for parenteral development

R C Rowe1, M G Wakerly, R J Roberts

  • 1ZENECA Pharmaceuticals, Macclesfield, Cheshire, United Kingdom.

PDA Journal of Pharmaceutical Science and Technology
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful Formulation Window for the design of pharmaceutical tablets with required mechanical properties.

International journal of pharmaceutics·2023
Same author

Potato Late Blight in the Columbia Basin: An Economic Analysis of the 1995 Epidemic.

Plant disease·2019
Same author

Effects of Quadrat Size and Time of Year for Sampling of Verticillium dahliae and Lesion Nematodes in Potato Fields.

Plant disease·2019
Same author

Molecular Characterization of Vegetative Compatibility Group 4A and 4B Isolates of Verticillium dahliae Associated with Potato Early Dying.

Plant disease·2019
Same author

Detection, Quantification, and Vegetative Compatibility of Verticillium dahliae in Potato and Mint Production Soils in the Columbia Basin of Oregon and Washington.

Plant disease·2019
Same author

Complete Genome Sequence and Methylome Analysis of Micrococcus luteus SA211, a Halophilic, Lithium-Tolerant Actinobacterium from Argentina.

Microbiology resource announcements·2019
Same journal

A PAT-aligned framework for installing and operating particle counting systems to detect pre-limit particle-size distribution shifts in ISO-8 (non-sterile) controlled areas.

PDA journal of pharmaceutical science and technology·2026
Same journal

Using Positive Controls to Define the Defect Detection Range for CCIT Method Development and Validation.

PDA journal of pharmaceutical science and technology·2026
Same journal

Patient-Centric Drug Delivery: Establishing Injection Hold Time Limits for Large Volume Autoinjectors.

PDA journal of pharmaceutical science and technology·2026
Same journal

Gas flow through micro-capillaries â which flow law is most suitable to predict the flow rate through micro-capillaries?

PDA journal of pharmaceutical science and technology·2026
Same journal

Peer Review.

PDA journal of pharmaceutical science and technology·2026
Same journal

In-situ Verification of Disinfection Rotation for Contamination Control.

PDA journal of pharmaceutical science and technology·2026
See all related articles

Expert systems offer significant advantages in parenteral development, enhancing knowledge protection, reducing costs, and improving training and communication. Case studies demonstrate their successful implementation in both academic and industrial settings.

Area of Science:

  • Pharmaceutical Sciences
  • Computer Science Applications in Medicine

Background:

  • Parenteral drug development is a complex process requiring extensive knowledge and rigorous quality control.
  • Expert systems offer a potential solution for managing and disseminating specialized knowledge in pharmaceutical development.

Purpose of the Study:

  • To introduce and review the application of expert systems in parenteral development.
  • To evaluate the benefits and practical implementation of expert systems through case studies.

Main Methods:

  • Review of existing literature on expert systems in pharmaceutical development.
  • Analysis of two case studies detailing the implementation of expert systems: one academic, one industrial.

Main Results:

Related Experiment Videos

  • Expert systems have demonstrated significant benefits in parenteral development.
  • Key benefits include enhanced knowledge protection, cost reduction, improved training, increased consistency, and better communication.

    • Conclusions:

    • The implementation of expert systems in parenteral development yields substantial advantages.
    • Expert systems are valuable tools for optimizing pharmaceutical development processes and knowledge management.